Mendelian randomization of circulating proteome identifies IFN-gamma as a druggable target in aplastic anemia. Qin S, Jiang Y, Ou Y, Zhan Y, et al. Ann Hematol 2024 Apr 22. doi: 10.1007/s00277-024-05746.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qin S, Jiang Y, Ou Y, Zhan Y, et al. Mendelian randomization of circulating proteome identifies IFN-gamma as a druggable target in aplastic anemia. Ann Hematol 2024 Apr 22. doi: 10.1007/s00277-024-05746.
PMID: 38644415